The epoch times

Fentanyl could become a Schedule I drug as House passes bill.

The HALT Fentanyl Act Passes House of Representatives

In an effort to combat the deadly opioid crisis, the House of Representatives passed the Halt All Lethal Trafficking (HALT) of Fentanyl Act on May 25.

Passing 289–133, the bipartisan legislation would strengthen penalties for fentanyl trafficking and was supported by President Joe Biden. Fentanyl would be listed as a Schedule I narcotic under the Controlled Substances Act.

Many House Republican members celebrated the bill’s passage, with Rep. Mike Johnson (R-La.) calling the bill “critical” as fentanyl continues to “invade all of our communities.”

On May 22, Biden called on Congress to pass the HALT Fentanyl Act, urging members “to pass all of these critical measures to improve public safety and save lives.”

Fentanyl, a synthetic opioid, has become a leading cause of overdose deaths in the United States. The HALT Fentanyl Act will increase penalties for those involved in fentanyl trafficking and provide additional resources for law enforcement agencies to tackle this illicit trade.

Civil Rights Groups Oppose the Bill

The bill’s Republican sponsor, Rep. Bob Latta (R-Ohio), wrote on Twitter on May 22, “Lives are on the line—77 percent of adolescent overdose deaths in 2021 were from illicit fentanyl poisonings.”

However, the bill has faced opposition from a coalition of 150 civil rights groups, who penned an open letter urging members of Congress to vote against the legislation. The groups, including the American Civil Liberties Union and Human Rights Watch, refer to the HALT Fentanyl Act as “yet another iteration of the drug war’s ineffective and punitive strategies.”

  • The emergence of fentanyl-related substances in recent years has fueled similar waves of alarmist media and law enforcement headlines that are informed by mythology rather than science,” the letter reads.
  • It points out that mandatory minimum sentences, which the bill seeks to expand, have historically contributed to mass incarceration and haven’t proven effective in reducing drug-related crimes.
  • The groups also expressed concern that the proposed legislation could hinder efforts to address the root causes of drug addiction, such as lack of access to treatment and socioeconomic disparities.
  • The signees said they prefer other proposals from House Democrats.

“This bill that they’re putting on the floor today, in my view, does not solve this problem,” Rep. Annie Kuster (D-N.H.) told The Epoch Times.

She noted that it doesn’t sufficiently focus on “long-term recovery because there’s a demand for these drugs that we need to tackle as well.”

Rep. Annie Kuster (D-N

The HALT Fentanyl Act has been passed by the House of Representatives in an effort to combat the deadly opioid crisis. The bipartisan legislation would strengthen penalties for fentanyl trafficking and was supported by President Joe Biden. Fentanyl would be listed as a Schedule I narcotic under the Controlled Substances Act. However, the bill has faced opposition from a coalition of 150 civil rights groups, who penned an open letter urging members of Congress to vote against the legislation. The groups, including the American Civil Liberties Union and Human Rights Watch, refer to the HALT Fentanyl Act as “yet another iteration of the drug war’s ineffective and punitive strategies.” The bill’s Republican sponsor, Rep. Bob Latta (R-Ohio), wrote on Twitter on May 22, “Lives are on the line—77 percent of adolescent overdose deaths in 2021 were from illicit fentanyl poisonings.” Fentanyl, a synthetic opioid, has become a leading cause of overdose deaths in the United States. The HALT Fentanyl Act will increase penalties for those involved in fentanyl trafficking and provide additional resources for law enforcement agencies to tackle this illicit trade.



" Conservative News Daily does not always share or support the views and opinions expressed here; they are just those of the writer."
*As an Amazon Associate I earn from qualifying purchases

Related Articles

Sponsored Content
Back to top button
Available for Amazon Prime
Close

Adblock Detected

Please consider supporting us by disabling your ad blocker